INDUSTRY NEWS: Remix Therapeutics reports encouraging clinical progress for its first-in-class MYB mRNA degrader REM-422 - Meet Them In November
INDUSTRY NEWS: Evotec announces a recent CRYO-EM breakthrough using structural biology - Explore These New Approaches in November

Advancing Splice Modulation from Mechanistic Insight to Candidate Progression & Clinical Confidence

12:59 pm - Wednesday 11th November 2026